Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1989-6-28
|
pubmed:abstractText |
It has been suggested that the molar ratio of octadeca 9,11 dienoic acid to linoleic acid in biological material provides an index of activity along the non-peroxide pathway of a free radical attack on polyunsaturated fatty acids. In 17 adults with cystic fibrosis the 'molar ratio' in nasal epithelial cells--a recognised target of the disease--exceeded that in 20 controls (median 2.09%, range 1.70-3.01% versus 1.56, 0.92-2.23%, p = 0.0002). The difference was also apparent, although less stark, upon analysis of serum in a further 22 CF patients (2.48%, 1.60-5.24%) and 25 controls (1.96%, 0.81-3.90%, p = 0.0348). There was no correlation between the 'molar ratio' and blood white cell count or erythrocyte sedimentation rate, severity of lung or liver disease, indicating that the raised values are a primary feature, rather than reflecting disease severity. Aberrant free radical activity may underlie cellular dysfunction in cystic fibrosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0009-8981
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
181
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
65-74
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2721006-Adolescent,
pubmed-meshheading:2721006-Adult,
pubmed-meshheading:2721006-Cystic Fibrosis,
pubmed-meshheading:2721006-Female,
pubmed-meshheading:2721006-Free Radicals,
pubmed-meshheading:2721006-Humans,
pubmed-meshheading:2721006-Linolenic Acids,
pubmed-meshheading:2721006-Lipid Peroxidation,
pubmed-meshheading:2721006-Male,
pubmed-meshheading:2721006-Nasal Mucosa,
pubmed-meshheading:2721006-Selenium
|
pubmed:year |
1989
|
pubmed:articleTitle |
Aberrant free radical activity in cystic fibrosis.
|
pubmed:affiliation |
Regional Adult Cystic Fibrosis Centre, Monsall Hospital Manchester, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|